Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

COVID-19 vaccines do not increase the risk of alopecia areata.

Trichoscopy helps diagnose and track alopecia areata by examining specific hair and scalp markers.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Men with alopecia often feel less confident and have lower wellbeing, needing more support.

Topical tofacitinib is effective and safe for treating alopecia areata.

Children with alopecia areata have more exclamation mark hairs and fewer yellow dots than adults.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Children with alopecia areata often have low vitamin D, especially if they have darker skin, it's not summer, or they're not White.

Excimer light therapy is more effective than low level laser therapy for treating alopecia areata.

Oral tofacitinib successfully treated total body hair loss in one patient.

Standard intralesional corticosteroids are the best treatment for patchy alopecia areata.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Alopecia areata causes significant stigma and emotional distress, with many affected individuals not receiving adequate support or treatment.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Hair follicles prevent NK cell attacks to avoid hair loss.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.